Navigation Links
Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
Date:12/18/2009

to have entered into a great partnership with Ambit," stated Masafumi Nogimori, president and chief executive officer of Astellas. "We believe that AC220, as the most selective and advanced FLT3 kinase inhibitor, has the potential to provide a new treatment option for AML where high unmet medical needs exist. Astellas is strongly committed to focus on oncology and this partnership is a significant milestone to establish our franchise in oncology."

"With their strategic commitment to the development and commercialization of innovative oncology products, Astellas is an ideal partner for Ambit," said Scott Salka, Chief Executive Officer of Ambit Biosciences. "This collaboration establishes a comprehensive and global leadership position in the discovery and development of FLT3 kinase inhibitors, and we look forward to working closely with Astellas to explore the clinical utility of AC220 in AML and other indications."

About AC220

AC220, Ambit's lead product candidate, is being developed in collaboration with Astellas Pharma Inc. and is a novel, potent, highly selective, orally bioavailable second-generation FLT3 inhibitor. AC220 is currently under evaluation in a Phase 2 clinical trial designed to support potential registration of AC220 as monotherapy treatment in adult and elderly patients with relapsed/refractory AML that have the internal tandem duplication (ITD) mutation in the FLT3 kinase. AML is one of the most common types of blood cancers in adults, and the FLT3 kinase is mutated and constitutively activated in 25-40 percent of such patients. FLT3 ITD mutations predict poor prognosis and decreased response to existing treatments, including chemotherapy and hematopoietic stem cell transplant. Ambit leveraged KINOMEscan(TM), the company's proprietary, high-throughput method for screening small molecule compounds against a large number of human kinases, to advance AC220 from initial chemistry to clinical candi
'/>"/>

SOURCE Ambit Biosciences Corporation; Astellas Pharma Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference
2. Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
3. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
4. CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices
5. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
6. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
7. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
8. Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
9. Cell Biosciences Completes Acquisition of Alpha Innotech
10. Neurocrine Biosciences Reports Third Quarter 2009 Results
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) ... America (London, UK - November 16-18, 2015)" conference to their offering. ... America including Columbia, Peru , ... , Uruguay , Paraguay , ... America , Chile This seminar ...
(Date:9/2/2015)... , Sept. 2, 2015  Research and ... of the "An Introduction to the Medical ... conference to their offering. ... European medical device legislation. It will explain the ... of Notified Bodies, how to choose one and ...
(Date:9/2/2015)... 2015 Demers Ambulances is proud to announce it ... dealer for the states of Mississippi , ... . "This will enable Demers to effectively ... , Executive Vice-President for Demers Ambulances. "Emergency Equipment Professionals has ... and Alabama , giving them a strategic ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2
... VIENNA, Austria, October 12 ... enzymes for the,chemical industry, announced today that it ... position of Senior Vice President Marketing &,Sales. Dr. ... of EUCODIS,Bioscience, products. In 2009 the Company has ...
... Foundation (CNF) today announced the launch of a new educational ... www.infantilespasmsinfo.org , is an educational resource developed by ... Spasms Awareness Week. , Earlier this year, the ... place this week in conjunction with the Child Neurology Society ...
Cached Medicine Technology:EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales 2EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales 3Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org 2Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org 3
(Date:9/3/2015)... York, New York (PRWEB) , ... September 03, 2015 , ... ... of the Division of Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical ... College. , Dr. Winchell is a nationally renowned expert in care for the critically ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Global Vision ... that it will be spotlighting its award-winning print and artwork inspection solutions, ScanProof ... September 16 and 17 at the Olympia London, booth #F33 , Be the first ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... its upcoming virtual conference, “Proven Pharmacy Benefit Strategies for a Rapidly Changing Marketplace.” ... Health, Express Scripts and Milliman, will discuss how plan sponsors are adopting bold, ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Hunters Creek ... Survivor Foundation with a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited ... for friends and family to enjoy Thanksgiving and Christmas with an extra big smile. ...
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
Breaking Medicine News(10 mins):Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2
... foods have a reputation for being full of flavor. ... for generations are,being prepared now in ways that can ... with high-calorie ingredients that,are fried or full of salt ... foods high in fat and calories can place people,at ...
... In New National Guidelines, WASHINGTON, Sept. 5 ... are getting a back-to-school boost,from the new asthma care ... primary importance of patient education,programs -- not just treatment ... their quality of life., Millions of children with ...
... Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty ... U.S. Food and Drug,Administration (FDA) product approval at its ... plans to seek FDA approval to,manufacture additional solid dosage ... is expected to be producing over 1 billion tablets,and ...
... Alliance is,offering an innovative program to help military leaders ... service to our country. Responding to the,needs of National ... author and nationally certified counselor, Joanne Steen, a widow,of ... Through a first-of-its-kind partnership, TriWest and Steen will ...
... Stahl Cowen Crowley LLC, of Chicago,IL, counsel to the ... Dana Corporation, Inc. has entered into a settlement,agreement with ... Dana had sought Bankruptcy Court approval to terminate all ... of the settlement Stahl,Cowen Crowley negotiated on behalf of ...
... Pet Owners to ... Surprise Attack, SACRAMENTO, Calif., Sept. 4 Most Californians ... encounters between,homeowners and wandering wildlife have prompted the California Veterinary,Medical ... what to,do to prevent an attack and how to react ...
Cached Medicine News:Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:School is Cool for Asthma Patients of All Ages 2Health News:Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility 2Health News:TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program 2Health News:Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee 2Health News:Wildlife Sightings on the Rise in California 2Health News:Wildlife Sightings on the Rise in California 3
... MCS + 9000 system is Haemonetics' latest ... portfolio of protocols for the collection of ... these. It also offers a range of ... of this system enables blood collection organizations ...
... The PCS2 system ... for the collection of ... allow for the collection ... platelet-poor plasma, platelet-poor plasma ...
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
... Finnpipette Stepper, a lightweight, easy-to-use ... dispensing up to 45 times ... universal Stepper handle is adapted ... cover a dispensing volume range ...
Medicine Products: